Common Surgical Diseases.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Common Surgical Diseases.Pdf Common Surgical Diseases Second Edition Common Surgical Diseases An Algorithmic Approach to Problem Solving Second Edition Edited by Jonathan A. Myers, MD Assistant Professor of Surgery Director, Undergraduate Surgical Education Rush Medical College of Rush University Rush University Medical Center Chicago, IL 60612, USA Keith W. Millikan, MD Professor of Surgery Associate Dean, Surgical Sciences and Services Rush Medical College of Rush University Rush University Medical Center Chicago, IL 60612, USA Theodore J. Saclarides, MD Professor of Surgery Head, Section of Colon and Rectal Surgery Rush Medical College of Rush University Rush University Medical Center Chicago, IL 60612, USA Jonathan A. Myers, MD Keith W. Millikan, MD Assistant Professor of Surgery Professor of Surgery Director, Undergraduate Surgical Education Associate Dean, Surgical Sciences and Services Rush Medical College of Rush University Rush Medical College of Rush University Rush University Medical Center Rush University Medical Center Chicago, IL 60612, USA Chicago, IL 60612, USA Theodore J. Saclarides, MD Professor of Surgery Head, Section of Colon and Rectal Surgery Rush Medical College of Rush University Rush University Medical Center Chicago, IL 60612, USA ISBN 978-0-387-75245-7 e-ISBN 978-0-387-75246-4 Library of Congress Control Number: 2007937163 © 2008 Springer Science+Business Media, LLC All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper 9 8 7 6 5 4 3 2 1 springer.com This book is dedicated to my wife, Beth, for her infinite patience, love, and support, and to our son, Jack, for his never-ending curiosity and boundless energy. Jonathan A. Myers To my parents, John and Joan, for making it all possible. To my wife, Janet, for her never-ending understanding and support of my career and, finally, to my children, Keith, Michael, Kyle, Kameron, Samantha, and John, for inspiring my optimism for the future. Keith W. Millikan I dedicate this to the physicians and healers whose work and lives have been a constant source of inspiration for me and countless others. May their memory be eternal. Theodore, Neofytos, John, Cosmas, Damian, Panteleimon, Nektarios, Savas, Herman, Rose. Theodore J. Saclarides Acknowledgments We are grateful to Steven G. Economou and Alexander Doolas for their encouragement and tutelage over the last several decades. Our deepest gratitude to Eileen Pehanich for her untiring efforts in the completion of this work. Jonathan A. Myers Keith W. Millikan Theodore J. Saclarides vii Foreword The printing of the 2nd edition of Common Surgical Dis- Solving is not only for residents and students or the young eases: An Algorithmic Approach to Problem Solving attests surgeon but also for all physicians who deal with surgical to its usefulness and popularity. Dr. Steven Economou, who patients. After all, a nonspecialist may not know the intricacies wrote the first foreword, died on April 7, 2007, and despite his of decision making for a Whipple operation and may order prolonged and debilitating illness, he retained his cheerful and a percutaneous biopsy or an ERCP when, regardless of the optimistic nature. Those of us who have been mentored by this result, the patient may or may not be a surgical candidate. great human being hope to emulate, but will probably never Common surgical diseases are not the only topics. There are achieve, his Olympian deeds as a surgeon, author, teacher, and at least 20 general topics on preoperative and postoperative leader. I am very honored to have been asked by the authors to care. Drs. Myers, Millikan, and Saclarides have taken advan- write the foreword for the 2nd edition. tage of the many talented attending physicians and residents Years ago, the resident or medical student was commended at Rush University to write most of the chapters. The authors for making a long list of obscure differential diagnoses regardless themselves wrote numerous chapters on their specialty. All the of the remoteness from the patient’s problem. Of course, these chapters were reviewed, corrected, and edited by the authors diagnoses have to be excluded or confirmed by numerous and they have left their indelible character in the text. This investigations, which could be painful, time consuming, book belongs in the pocket of residents and students and on dangerous, and costly. One might say that having many diag- the desk of practicing physicians who deal with a wide range noses and performing many tests protects the physician from of patients. litigation. In fact, it will do the opposite if they are not appropriate Alexander Doolas, MD and complications arise. Medicine has turned from performing Rush Medical College of Rush University too many investigations to expeditious and concise “evidence- Rush University Medical Center based medicine.” The authors have predated this trend by a Chicago, IL few years and the printing of the 2nd edition is timely. Common Surgical Diseases: An Algorithmic Approach to Problem ix Contents Acknowledgments . vii Foreword . ix Contributors . xix Part I General Preoperative Considerations 1. Assessing Preoperative Cardiac Risk in Patients Undergoing Noncardiac Surgery. 3 David M. Rothenberg 2. Management of Preoperative Bleeding Disorders–Intraoperative Coagulopathy. 7 Jeffrey Shuhaiber and Jonathan Silverstein 3. Preoperative Nutritional Assessment/Intervention . 11 Janet D. Millikan 4. Transfusion Reactions. 15 Jennifer B. Manders 5. Asymptomatic Carotid Bruits . 19 Joseph D. Vijungco 6. General Operating Room Precautions . 23 Jonathan A. Myers Part II Trauma 7. Initial Assessment and Resuscitation of the Trauma Patient . 29 Frederic Starr 8. Head Trauma. 33 Laura B. Petrey 9. Management of the Difficult Airway . 37 Kimberly O. Nagy 10. Penetrating Neck Trauma . 41 Mark Falimirski xi xii Contents 11. Penetrating Chest Trauma. 45 Marie Crandall 12. Penetrating Abdominal Trauma . 49 James M. Waltenberger 13. Blunt Abdominal Trauma . 53 Marie Crandall 14. Pelvic Fractures. 57 Benjamin P. Crane 15. Traumatic Hematuria . 61 Carlos R. Estrada, Jr. 16. Knee Pain . 65 Anca Lamse and Charles A. Bush-Joseph 17. Shoulder Pain . 69 Anca Lamse and Charles A. Bush-Joseph 18. Hip Fractures. 73 Eric M. Berkson 19. Extremity Fractures. 75 Eric M. Berkson 20. Burns. 79 Laura J. Moore Part III Vascular Problems 21. Chronic Lower Extremity Ischemia . 85 Chad E. Jacobs 22. The Acute Cold Leg . 89 Peter Y. Wong 23. Myocardial Infarction . 93 Clifford J. Kavinsky and Paul W. McMullan 24. Abdominal Aortic Aneurysm . 97 Bernadette Aulivola Part IV Endocrine Disorders 25. Solitary Thyroid Nodule and Cancer . 103 Christine A. Chu and William B. Inabnet 26. Cushing’s Syndrome . 107 David Baldwin, Jr. 27. Hyperthyroidism . 111 Subhash Patel Contents xiii 28. Hypercalcemia . 115 Michael D. Addis and William B. Inabnet 29. Insulinoma. 119 Geoffrey B. Thompson 30. Zollinger Ellison Syndrome . 123 Anthony W. Kim and Harry M. Richter, III 31. Surgical Hypertension: Evaluation and Treatment . ..
Recommended publications
  • Guidelines for the Management of Hereditary Colorectal Cancer
    Guidelines Guidelines for the management of hereditary Gut: first published as 10.1136/gutjnl-2019-319915 on 28 November 2019. Downloaded from colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/ United Kingdom Cancer Genetics Group (UKCGG) Kevin J Monahan ,1,2 Nicola Bradshaw,3 Sunil Dolwani,4 Bianca Desouza,5 Malcolm G Dunlop,6 James E East,7,8 Mohammad Ilyas,9 Asha Kaur,10 Fiona Lalloo,11 Andrew Latchford,12 Matthew D Rutter ,13,14 Ian Tomlinson ,15,16 Huw J W Thomas,1,2 James Hill,11 Hereditary CRC guidelines eDelphi consensus group ► Additional material is ABSTRact having a family history of a first-degree relative published online only. To view Heritable factors account for approximately 35% of (FDR) or second degree relative (SDR) with CRC.2 please visit the journal online (http:// dx. doi. org/ 10. 1136/ colorectal cancer (CRC) risk, and almost 30% of the While highly penetrant syndromes such as Lynch gutjnl- 2019- 319915). population in the UK have a family history of CRC. syndrome (LS), familial adenomatous polyposis (FAP) The quantification of an individual’s lifetime risk of and other polyposis syndromes account for account For numbered affiliations see end of article. gastrointestinal cancer may incorporate clinical and for only 5–10% of all CRC diagnoses, advances molecular data, and depends on accurate phenotypic in genetic diagnosis, improvements in endoscopic Correspondence to assessment and genetic diagnosis. In turn this may surgical control, and medical and lifestyle interven- Dr Kevin J Monahan, Family facilitate targeted risk-reducing interventions, including tions provide opportunities for CRC prevention and Cancer Clinic, St Mark’s endoscopic surveillance, preventative surgery and effective treatment in susceptible individuals.
    [Show full text]
  • Appendix Cancer and Pseudomyxoma Peritonei (PMP) a Guide for People Affected by Cancer
    Cancer information fact sheet Understanding Appendix Cancer and Pseudomyxoma Peritonei (PMP) A guide for people affected by cancer This fact sheet has been prepared What is appendix cancer? to help you understand more about Appendix cancer occurs when cells in the appendix appendix cancer and pseudomyxoma become abnormal and keep growing and form a peritonei (PMP). mass or lump called a tumour. Many people look for support after The type of cancer is defined by the particular being diagnosed with a cancer that cells that are affected and can be benign (non- is rare or less common than other cancerous) or malignant (cancerous). Malignant cancer types. This fact sheet includes tumours have the potential to spread to other information about how these cancers parts of the body through the blood stream or are diagnosed and treated, as well as lymph vessels and form another tumour at a where to go for additional information new site. This new tumour is known as secondary and support services. cancer or metastasis. Many people feel shocked and upset when told they have cancer. You may experience strong emotions The abdomen after a cancer diagnosis, especially if your cancer is rare or less common like appendix cancer or PMP. A feeling of being alone is usual with rare cancers, and you might be worried about how much is known about your type of cancer as well as how it will be managed. You may also be concerned about the cancer coming back after treatment. Linking into local support services (see last page) can help overcome feelings of isolation and will give you information that you may find useful.
    [Show full text]
  • The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes Daniel Herzig, M.D
    CLINICAL PRACTICE GUIDELINES The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes Daniel Herzig, M.D. • Karin Hardimann, M.D. • Martin Weiser, M.D. • Nancy Yu, M.D. Ian Paquette, M.D. • Daniel L. Feingold, M.D. • Scott R. Steele, M.D. Prepared by the Clinical Practice Guidelines Committee of The American Society of Colon and Rectal Surgeons he American Society of Colon and Rectal Surgeons METHODOLOGY (ASCRS) is dedicated to ensuring high-quality pa- tient care by advancing the science, prevention, and These guidelines are built on the last set of the ASCRS T Practice Parameters for the Identification and Testing of management of disorders and diseases of the colon, rectum, Patients at Risk for Dominantly Inherited Colorectal Can- and anus. The Clinical Practice Guidelines Committee is 1 composed of society members who are chosen because they cer published in 2003. An organized search of MEDLINE have demonstrated expertise in the specialty of colon and (1946 to December week 1, 2016) was performed from rectal surgery. This committee was created to lead interna- 1946 through week 4 of September 2016 (Fig. 1). Subject tional efforts in defining quality care for conditions related headings for “adenomatous polyposis coli” (4203 results) to the colon, rectum, and anus, in addition to the devel- and “intestinal polyposis” (445 results) were included, us- opment of Clinical Practice Guidelines based on the best ing focused search. The results were combined (4629 re- available evidence. These guidelines are inclusive and not sults) and limited to English language (3981 results), then prescriptive.
    [Show full text]
  • Familial Adenomatous Polyposis Polymnia Galiatsatos, M.D., F.R.C.P.(C),1 and William D
    American Journal of Gastroenterology ISSN 0002-9270 C 2006 by Am. Coll. of Gastroenterology doi: 10.1111/j.1572-0241.2006.00375.x Published by Blackwell Publishing CME Familial Adenomatous Polyposis Polymnia Galiatsatos, M.D., F.R.C.P.(C),1 and William D. Foulkes, M.B., Ph.D.2 1Division of Gastroenterology, Department of Medicine, The Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada, and 2Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada Familial adenomatous polyposis (FAP) is an autosomal-dominant colorectal cancer syndrome, caused by a germline mutation in the adenomatous polyposis coli (APC) gene, on chromosome 5q21. It is characterized by hundreds of adenomatous colorectal polyps, with an almost inevitable progression to colorectal cancer at an average age of 35 to 40 yr. Associated features include upper gastrointestinal tract polyps, congenital hypertrophy of the retinal pigment epithelium, desmoid tumors, and other extracolonic malignancies. Gardner syndrome is more of a historical subdivision of FAP, characterized by osteomas, dental anomalies, epidermal cysts, and soft tissue tumors. Other specified variants include Turcot syndrome (associated with central nervous system malignancies) and hereditary desmoid disease. Several genotype–phenotype correlations have been observed. Attenuated FAP is a phenotypically distinct entity, presenting with fewer than 100 adenomas. Multiple colorectal adenomas can also be caused by mutations in the human MutY homologue (MYH) gene, in an autosomal recessive condition referred to as MYH associated polyposis (MAP). Endoscopic screening of FAP probands and relatives is advocated as early as the ages of 10–12 yr, with the objective of reducing the occurrence of colorectal cancer.
    [Show full text]
  • Carcinoid Tumor of Appendix: Review of Consecutive 5131 Appendectomy
    J Surg Med. 2018;2(2):134-136. Research article DOI: 10.28982/josam.414055 Araştırma makalesi Carcinoid tumor of appendix: Review of consecutive 5131 appendectomy Apendiksin karsinoid tümörü: Ardışık 5131 apendektominin incelemesi İlyas Kudaş 1, Olgun Erdem 2, Ahmet Topçu 2, Abdullah Şişik 2 1 Department of General Surgery, Abstract Tekman State Hospital, Erzurum, Aim: Appendiceal carcinoid tumor (neuroendocrine tumor) is rarely seen, and it is frequently found incidentally Turkey after evaluation of appendectomy specimen. Histopathologically, the appendiceal carcinoid tumor is usually the 2 Department of General Surgery, University of Health Science, Umraniye type of enterochromafine cell and stems from a sub-epithelial cell population that differs from the Education and Research Hospital, neuroendocrine tumor in other regions. Although it is often detected in appendectomy, appendiceal one is the Istanbul, Turkey most common type of primary malignant lesion and is detected in 0.3-0.9% of patients with appendectomy. In this study, it is intended to present an appendix carcinoid tumor series that is diagnosed incidentally after appendectomy. Methods: 5131 appendectomy that was performed between years of 2009 and 2017 constituted the study universe. 35 (0.68%) patients diagnosed with carcinoid tumors were evaluated in the histopathological examination. The patients were recorded in terms of demographic data, clinical status, histopathology and surgical reports. Additional operations and follow-up data were noted. Results: 21 of the 35 patients with appendiceal carcinoid tumors were males, and 14 were women. Male/Female ratio was 1.5. The mean age of the patients was 27.3±11.0. There was no difference in terms of gender and age with other appendectomy patients who diagnosed non-tumor (p=0.476 and p=0.413, respectively).
    [Show full text]
  • Integrated Clinico-Molecular Profiling of Appendiceal Adenocarcinoma
    www.nature.com/bjc ARTICLE Molecular Diagnostics Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer Kanwal Raghav 1, John P. Shen1, Alexandre A. Jácome1, Jennifer L. Guerra1, Christopher P. Scally2, Melissa W. Taggart3, Wai C. Foo3, Aurelio Matamoros4, Kenna R. Shaw5, Keith Fournier2, Michael J. Overman1 and Cathy Eng1 BACKGROUND: Appendiceal adenocarcinoma (AA) is an orphan disease with unique clinical attributes but often treated as colorectal cancer (CRC). Understanding key molecular differences between AA and CRC is critical. METHODS: We performed retrospective analyses of AA patients (N = 266) with tumour and/or blood next-generation sequencing (NGS) (2013–2018) with in-depth clinicopathological annotation. Overall survival (OS) was examined. For comparison, CRC cohorts annotated for sidedness, consensus molecular subtypes (CMS) and mutations (N = 3283) were used. RESULTS: Blood-NGS identified less RAS/GNAS mutations compared to tissue-NGS (4.2% vs. 60.9%, P < 0.0001) and showed poor concordance with tissue for well-/moderately differentiated tumours. RAS (56.2%), GNAS (28.1%) and TP53 (26.9%) were most frequent mutations. Well/moderately differentiated tumours harboured more RAS (69.2%/64.0% vs. 40.5%) and GNAS (48.7%/32.0% vs. 10.1%) while moderate/poorly differentiated tumours had more TP53 (26.0%/27.8% vs. 7.7%) mutations. Appendiceal adenocarcinoma (compared to CRC) harboured significantly fewer APC (9.1% vs. 55.4%) and TP53 (26.9% vs. 67.5%) and more GNAS mutations (28.1% vs. 2.0%) (P < 0.0001). Appendiceal adenocarcinoma mutation profile did not resemble either right-sided CRC or any of the four CMS in CRC.
    [Show full text]
  • Effect Modification of Vitamin D Supplementation By
    nutrients Article Effect Modification of Vitamin D Supplementation by Histopathological Characteristics on Survival of Patients with Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial Hideyuki Yonaga 1,2, Shinya Okada 3 , Taisuke Akutsu 1, Hironori Ohdaira 4, Yutaka Suzuki 4 and Mitsuyoshi Urashima 1,* 1 Division of Molecular Epidemiology, The Jikei University School of Medicine, 3–25–8, Nishi-Shimbashi, Minato-Ku, Tokyo 105-8461, Japan; [email protected] (H.Y.); [email protected] (T.A.) 2 Celgene K. K., JP TOWER 2–7–2 Marunouchi Chiyoda-ku, Tokyo 100-7010, Japan; [email protected] 3 Department of Pathology, International University of Health and Welfare Hospital, 537–3 Iguchi, Nasushiobara, Tochigi 329-2763, Japan; [email protected] 4 Department of Surgery, International University of Health and Welfare Hospital, 537–3 Iguchi, Nasushiobara, Tochigi 329-2763, Japan; [email protected] (H.O.); [email protected] (Y.S.) * Correspondence: [email protected]; Tel.: +81-3-3433-1111 (ext. 2405) Received: 13 September 2019; Accepted: 21 October 2019; Published: 22 October 2019 Abstract: Some coauthors of this study previously performed the AMATERASU randomized, double-blind, placebo-controlled trial of postoperative oral vitamin D supplementation (2000 IU/day) in 417 patients with stage I to III digestive tract cancer from the esophagus to the rectum who underwent curative surgery (UMIN000001977). We conducted a post-hoc analysis of the AMATERASU trial to explore the effects of modification of vitamin D supplementation by histopathological characteristics on survival. Among patients with poorly differentiated adenocarcinoma, the 5-year relapse-free survival rate of patients supplemented with vitamin D was 91% compared with 63% in the placebo group (hazard ratio [HR], 0.25; 95% confidence interval [CI], 0.08 to 0.78; P = 0.017; P for interaction = 0.023).
    [Show full text]
  • Risk Factors Associated with Rectal Neuroendocrine Tumors: a Cross-Sectional Study
    Author Manuscript Published OnlineFirst on May 9, 2014; DOI: 10.1158/1055-9965.EPI-14-0132 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Risk Factors Associated with Rectal Neuroendocrine Tumors: A Cross-Sectional Study Yoon Suk Jung1, Kyung Eun Yun2, Yoosoo Chang2,3, Seungho Ryu2,3, Jung Ho Park1, Hong Joo Kim1, Yong Kyun Cho1, Chong Il Sohn1, Woo Kyu Jeon1, Byung Ik Kim1, and Dong Il Park1 1Department of Internal Medicine, 2Center for Cohort Studies, Total Healthcare Center, 3Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, Korea Running title: Risk factors for rectal neuroendocrine tumors Corresponding author: Dong Il Park, MD, PhD Department of Internal Medicine Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine 108, Pyung-Dong, Jongro-Ku, Seoul, Korea 110-746 Phone: +82-2-2001-2059, Fax: +82-2-2001-2049 E-mail: [email protected] Disclosure of Potential Conflicts of Interest: We have nothing to disclose. 1 Downloaded from cebp.aacrjournals.org on October 1, 2021. © 2014 American Association for Cancer Research. Author Manuscript Published OnlineFirst on May 9, 2014; DOI: 10.1158/1055-9965.EPI-14-0132 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract Background: The incidence of rectal neuroendocrine tumors (NETs) has been increasing since the implementation of the screening colonoscopy. However, very little is known about risk factors associated with rectal NETs. We examined the prevalence of and the risk factors for rectal NETs in a Korean population.
    [Show full text]
  • (ACRCSP) Post Polypectomy Surveillance Guidelines
    Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines June 2013 ACRCSP Post Polypectomy Surveillance Guidelines - 2 TABLE OF CONTENTS Background ………………………………………………………………………………………... 3 Terms, Definitions and Practical Points……………………………………………………….. 4 Post Colonoscopy Screening……………………………………………………………………. 5 Post Polypectomy Surveillance…………………………………………………………………..6 References ………………………………………………………………………………………….12 ACRCSP Post Polypectomy Surveillance Guidelines - 3 Background Adherence to evidence based guidelines is supported by the reduction of interval colorectal cancers and colorectal cancer (CRC)- related mortality. Surveillance interval guidelines are based on the presumption that a high quality baseline colonoscopy was performed (i.e. that the colonoscopy was completed to the cecum, and that the colonic mucosa was well visualized). It is also important to ensure the completeness of polypectomy and that all polypectomy material was sent to pathology. Patients with a failed colonoscopy (for example due to inability to reach cecum or poor bowel preparation) should undergo repeat colonoscopy (either by same operator or referred, depending on the reason why the colonoscopy was incomplete) or, less preferably, diagnostic imaging of the colon by CT colonography. A system should be in place to ensure that all pathology reports are reviewed and that recommendations to primary care physician regarding surveillance intervals are adjusted as indicated. Endoscopists should make clear recommendations to primary care physicians about the need for and timing of subsequent colonoscopy. Considering that the recommendation largely depends on the histological findings, interval recommendation in patients with polyps should account for the pathology report instead of being made at the time of colonoscopy. The decision regarding surveillance interval should be based on the most advanced finding(s) at baseline colonoscopy.
    [Show full text]
  • Location of Colorectal Adenomas and Serrated Polyps in Patients Under Age 50
    International Journal of Colorectal Disease (2019) 34:2201–2204 https://doi.org/10.1007/s00384-019-03445-5 SHORT COMMUNICATION Location of colorectal adenomas and serrated polyps in patients under age 50 Zexian Chen1,2 & Jiancong Hu1,2 & Zheyu Zheng1,2 & Chao Wang3 & Dezheng Lin1 & Yan Huang3 & Ping Lan1,2 & Xiaosheng He1,2 Accepted: 25 October 2019 /Published online: 18 November 2019 # Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Background The incidence of colorectal cancer, especially located in distal colorectum, is rising markedly in young patients. Conventional adenomas and serrated polyps have been widely recognized as precursors of colorectal cancer. Aim To investigate the correlation of polyp feature with polyp location in patients under age 50. Method Patients under age 50 who had received colonoscopy were included from 2010 to 2018. Clinical data including number, location, size, and histopathology of polyps were collected. Odd ratios and 95% confidence interval of adenomas with their location were calculated. Result In total, 25,636 patients aged 18–49 were enrolled, among which 4485 patients had polyps, with polyp detection rate of 17.5%. A total of 2484 and 2387 patients had conventional adenomas and serrated polyps, respectively. 76.0% advanced adenomas and 69.5% ≥ 10-mm serrated polyps were located in the distal colorectum. The detection rate of advanced adenomas was higher in patients aged 45–49. Patients with adenomas especially advanced adenomas in the distal colorectum were more likely to have advanced adenoma in the proximal colon. Conclusion Among patients under age 50, advanced adenomas and ≥ 10-mm serrated polyps were predominantly in the distal colorectum.
    [Show full text]
  • Increased EZH2 Expression During the Adenoma‑Carcinoma Sequence in Colorectal Cancer
    ONCOLOGY LETTERS 16: 5275-5281, 2018 Increased EZH2 expression during the adenoma‑carcinoma sequence in colorectal cancer MAYUKO OHUCHI1, YASUO SAKAMOTO1, RYUMA TOKUNAGA1, YUKI KIYOZUMI1, KENICHI NAKAMURA1, DAISUKE IZUMI1, KEISUKE KOSUMI1, KAZUTO HARADA1, JUNJI KURASHIGE1, MASAAKI IWATSUKI1, YOSHIFUMI BABA1, YUJI MIYAMOTO1, NAOYA YOSHIDA1, TAKASHI SHONO2, HIDEAKI NAOE2, YUTAKA SASAKI2 and HIDEO BABA1 Departments of 1Gastroenterological Surgery, and 2Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan Received December 13, 2016; Accepted May 11, 2017 DOI: 10.3892/ol.2018.9240 Abstract. The adenoma-carcinoma sequence, the sequential from formalin‑fixed paraffin‑embedded blocks and reverse mutation and deletion of various genes by which colorectal transcription-quantitative polymerase chain reaction analysis cancer progresses, is a well-established and accepted concept of these genes was performed. Ki-67 and EZH2 expression of colorectal cancer carcinogenesis. Proteins of the polycomb scores increased significantly during the progression of repressive complex 2 (PRC2) function as transcriptional normal mucosa to adenoma and carcinoma (P=0.009), and repressors by trimethylating histone H3 at lysine 27; the EZH2 expression score was positively associated with Ki-67 activity of this complex is essential for cell proliferation expression score (P=0.02). Conversely, p21 mRNA and and differentiation. The histone methyltransferase enhancer protein expression decreased significantly, whereas expression of zeste homolog 2 (EZH2), an essential component of of p27 and p16 did not change significantly. During the PRC2, is associated with the transcriptional repression of carcinogenesis sequence from normal mucosa to adenoma and tumor suppressor genes. EZH2 expression has previously carcinoma, EZH2 expression increased and p21 expression been reported to increase with the progression of pancreatic decreased significantly.
    [Show full text]
  • Copyrighted Material
    Subject index Note: page numbers in italics refer to fi gures, those in bold refer to tables Abbreviations used in subentries abdominal mass patterns 781–782 GERD – gastroesophageal refl ux disease choledochal cysts 1850 perception 781 IBD – infl ammatory bowel disease mesenteric panniculitis 2208 periodicity 708–709 mesenteric tumors 2210 peripheral neurogenic 2429 A omental tumors 2210 pharmacological management 714–717 ABCB1/MDR1 484 , 633 , 634–636 abdominal migrane (AM) 712 , 2428–2429 physical examination 709–710 , 710 ABCB4 abdominal obesity 2230 postprandial 2498–2499 c h o l e s t e r o l g a l l s t o n e s 1817–1818 , abdominal pain 695–722 in pregnancy 842 1819–1820 a c u t e see acute abdominal pain prevalence 695 functions 483–484 , 1813 acute cholecystitis 784 rare/obscure causes 712–713 , 712 intrahepatic cholestasis of pregnancy 848 acute diverticulitis 794–796 , 795 , 1523–1524 , red fl ags 713 low phospholipid-associated 1527 relieving/aggravating factors 709 cholelithiasis 1810 , 1819–1820 , 2393 acute mesenteric ischemia 2492 right lower quadrant 794 m u t a t i o n p h e n o t y p e s 2392 , 2393 a c u t e p a n c r e a t i t i s 795 , 1653 , 1667 right upper quadrant 794 progressive familial intrahepatic cholestasis-3 acute suppurative peritonitis 2196 sickle cell crisis 2419 494 adhesions 713 s i t e 703 , 708 ABCB11 see bile salt export pump (BSEP) AIDS 2200 special pain syndromes 718–720 ABCC2/MRP2 485 , 494 , 870 , 1813 , 2394 , 2395 anxiety 706–707 sphincter of Oddi dysfunction 1877 ABCG2/BCRP 484–485 , 633
    [Show full text]